A citation-based method for searching scientific literature


List of co-cited articles
548 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Luis Sordo, Gregorio Barrio, Maria J Bravo, B Iciar Indave, Louisa Degenhardt, Lucas Wiessing, Marica Ferri, Roberto Pastor-Barriuso. BMJ 2017
809
23

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Richard P Mattick, Courtney Breen, Jo Kimber, Marina Davoli. Cochrane Database Syst Rev 2014
864
18

Medication-assisted therapies--tackling the opioid-overdose epidemic.
Nora D Volkow, Thomas R Frieden, Pamela S Hyde, Stephen S Cha. N Engl J Med 2014
639
17

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
Richard P Mattick, Courtney Breen, Jo Kimber, Marina Davoli. Cochrane Database Syst Rev 2009
851
16

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Joshua D Lee, Edward V Nunes, Patricia Novo, Ken Bachrach, Genie L Bailey, Snehal Bhatt, Sarah Farkas, Marc Fishman, Phoebe Gauthier, Candace C Hodgkins,[...]. Lancet 2018
341
14


Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Marc R Larochelle, Dana Bernson, Thomas Land, Thomas J Stopka, Na Wang, Ziming Xuan, Sarah M Bagley, Jane M Liebschutz, Alexander Y Walley. Ann Intern Med 2018
448
12

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
Yih-Ing Hser, Andrew J Saxon, David Huang, Al Hasson, Christie Thomas, Maureen Hillhouse, Petra Jacobs, Cheryl Teruya, Paul McLaughlin, Katharina Wiest,[...]. Addiction 2014
244
9

Retention in medication-assisted treatment for opiate dependence: A systematic review.
Christine Timko, Nicole R Schultz, Michael A Cucciare, Lisa Vittorio, Christina Garrison-Diehn. J Addict Dis 2016
213
9

Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
Gail D'Onofrio, Patrick G O'Connor, Michael V Pantalon, Marek C Chawarski, Susan H Busch, Patricia H Owens, Steven L Bernstein, David A Fiellin. JAMA 2015
464
8

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.
Christopher M Jones, Melinda Campopiano, Grant Baldwin, Elinore McCance-Katz. Am J Public Health 2015
442
8

Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
Jun Ma, Yan-Ping Bao, Ru-Jia Wang, Meng-Fan Su, Mo-Xuan Liu, Jin-Qiao Li, Louisa Degenhardt, Michael Farrell, Frederic C Blow, Mark Ilgen,[...]. Mol Psychiatry 2019
117
8

An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.
Laura Amato, Marina Davoli, Carlo A Perucci, Marica Ferri, Fabrizio Faggiano, Richard P Mattick. J Subst Abuse Treat 2005
340
7

Treatment of Opioid-Use Disorders.
Marc A Schuckit. N Engl J Med 2016
280
7

Medication-assisted treatment with methadone: assessing the evidence.
Catherine Anne Fullerton, Meelee Kim, Cindy Parks Thomas, D Russell Lyman, Leslie B Montejano, Richard H Dougherty, Allen S Daniels, Sushmita Shoma Ghose, Miriam E Delphin-Rittmon. Psychiatr Serv 2014
145
7

Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
Lawrence Scholl, Puja Seth, Mbabazi Kariisa, Nana Wilson, Grant Baldwin. MMWR Morb Mortal Wkly Rep 2018
7


Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
Sarah E Wakeman, Marc R Larochelle, Omid Ameli, Christine E Chaisson, Jeffrey Thomas McPheeters, William H Crown, Francisca Azocar, Darshak M Sanghavi. JAMA Netw Open 2020
238
7

Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.
Rose A Rudd, Puja Seth, Felicita David, Lawrence Scholl. MMWR Morb Mortal Wkly Rep 2016
6

Clinical pharmacology of buprenorphine: ceiling effects at high doses.
S L Walsh, K L Preston, M L Stitzer, E J Cone, G E Bigelow. Clin Pharmacol Ther 1994
522
6


Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
Peter D Friedmann, Randall Hoskinson, Michael Gordon, Robert Schwartz, Timothy Kinlock, Kevin Knight, Patrick M Flynn, Wayne N Welsh, Lynda A R Stein, Stanley Sacks,[...]. Subst Abus 2012
119
6

Opioid dependence treatment: options in pharmacotherapy.
Angela L Stotts, Carrie L Dodrill, Thomas R Kosten. Expert Opin Pharmacother 2009
148
6



Why aren't physicians prescribing more buprenorphine?
Andrew S Huhn, Kelly E Dunn. J Subst Abuse Treat 2017
161
6

Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review.
Leonieke C van Boekel, Evelien P M Brouwers, Jaap van Weeghel, Henk F L Garretsen. Drug Alcohol Depend 2013
671
6

A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction.
Jennifer C Veilleux, Peter J Colvin, Jennifer Anderson, Catherine York, Adrienne J Heinz. Clin Psychol Rev 2010
186
6

Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
Gail D'Onofrio, Marek C Chawarski, Patrick G O'Connor, Michael V Pantalon, Susan H Busch, Patricia H Owens, Kathryn Hawk, Steven L Bernstein, David A Fiellin. J Gen Intern Med 2017
133
5

Confronting the stigma of opioid use disorder--and its treatment.
Yngvild Olsen, Joshua M Sharfstein. JAMA 2014
165
5

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
Joshua D Lee, Peter D Friedmann, Timothy W Kinlock, Edward V Nunes, Tamara Y Boney, Randall A Hoskinson, Donna Wilson, Ryan McDonald, John Rotrosen, Marc N Gourevitch,[...]. N Engl J Med 2016
190
5

Barriers to primary care physicians prescribing buprenorphine.
Eliza Hutchinson, Mary Catlin, C Holly A Andrilla, Laura-Mae Baldwin, Roger A Rosenblatt. Ann Fam Med 2014
166
5

Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.
Rebecca L Haffajee, Amy S B Bohnert, Pooja A Lagisetty. Am J Prev Med 2018
118
5

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
Roger D Weiss, Jennifer Sharpe Potter, David A Fiellin, Marilyn Byrne, Hilary S Connery, William Dickinson, John Gardin, Margaret L Griffin, Marc N Gourevitch, Deborah L Haller,[...]. Arch Gen Psychiatry 2011
339
5

Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.
Robert P Schwartz, Jan Gryczynski, Kevin E O'Grady, Joshua M Sharfstein, Gregory Warren, Yngvild Olsen, Shannon G Mitchell, Jerome H Jaffe. Am J Public Health 2013
184
5

Medication-assisted treatment with buprenorphine: assessing the evidence.
Cindy Parks Thomas, Catherine Anne Fullerton, Meelee Kim, Leslie Montejano, D Russell Lyman, Richard H Dougherty, Allen S Daniels, Sushmita Shoma Ghose, Miriam E Delphin-Rittmon. Psychiatr Serv 2014
131
5


Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
K L Sees, K L Delucchi, C Masson, A Rosen, H W Clark, H Robillard, P Banys, S M Hall. JAMA 2000
273
5

Treatment utilization among persons with opioid use disorder in the United States.
Li-Tzy Wu, He Zhu, Marvin S Swartz. Drug Alcohol Depend 2016
197
5



Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
Lars Tanum, Kristin Klemmetsby Solli, Zill-E-Huma Latif, Jurate Šaltyte Benth, Arild Opheim, Kamni Sharma-Haase, Peter Krajci, Nikolaj Kunøe. JAMA Psychiatry 2017
142
4


Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
David A Fiellin, Richard S Schottenfeld, Christopher J Cutter, Brent A Moore, Declan T Barry, Patrick G O'Connor. JAMA Intern Med 2014
117
4

A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction.
Karen Dugosh, Amanda Abraham, Brittany Seymour, Keli McLoyd, Mady Chalk, David Festinger. J Addict Med 2016
150
4


The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
Michael Soyka, Henry R Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller, Siegfried Kasper. World J Biol Psychiatry 2011
72
5

Methadone--metabolism, pharmacokinetics and interactions.
Anna Ferrari, Ciro Pio Rosario Coccia, Alfio Bertolini, Emilio Sternieri. Pharmacol Res 2004
230
4

Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
Gery P Guy, Kun Zhang, Michele K Bohm, Jan Losby, Brian Lewis, Randall Young, Louise B Murphy, Deborah Dowell. MMWR Morb Mortal Wkly Rep 2017
703
4

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.
Deborah Dowell, Tamara M Haegerich, Roger Chou. JAMA 2016
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.